These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16234539)

  • 1. Mafosfamide: a new intra-CSF chemotherapy?
    Chamberlain MC
    J Clin Oncol; 2005 Oct; 23(30):7748-9; author reply 7749. PubMed ID: 16234539
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
    Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
    J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
    Slavc I; Schuller E; Falger J; Günes M; Pillwein K; Czech T; Dietrich W; Rössler K; Dieckmann K; Prayer D; Hainfellner J
    J Neurooncol; 2003 Sep; 64(3):239-47. PubMed ID: 14558599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
    Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
    J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of intrathecal 4-hydroperoxycyclophosphamide in a nude rat model of human neoplastic meningitis.
    Fuchs HE; Archer GE; Colvin OM; Bigner SH; Schuster JM; Fuller GN; Muhlbaier LH; Schold SC; Friedman HS; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1954-9. PubMed ID: 2306744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 111Indium-diethylenetriamine pentaacetic acid CSF flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases.
    Chamberlain MC; Kormanik P; Jaeckle KA; Glantz M
    Neurology; 1999 Jan; 52(1):216-7. PubMed ID: 9921888
    [No Abstract]   [Full Text] [Related]  

  • 7. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New cytotoxic drugs for intrathecal administration.
    Blaney SM; Poplack DG
    J Neurooncol; 1998; 38(2-3):219-23. PubMed ID: 9696375
    [No Abstract]   [Full Text] [Related]  

  • 9. Current options for the treatment of neoplastic meningitis.
    Cokgor I; Friedman AH; Friedman HS
    J Neurooncol; 2002 Oct; 60(1):79-88. PubMed ID: 12416549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic strategies for the treatment of meningeal malignancy.
    Blaney SM; Poplack DG
    Invest New Drugs; 1996; 14(1):69-85. PubMed ID: 8880395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic meningitis: diagnosis and treatment considerations.
    Blaney SM; Poplack DG
    Med Oncol; 2000 Aug; 17(3):151-62. PubMed ID: 10962524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mafosfamide as a new anticancer agent: preclinical investigations and clinical trials.
    Mazur L; Opydo-Chanek M; Stojak M; Wojcieszek K
    Anticancer Res; 2012 Jul; 32(7):2783-9. PubMed ID: 22753738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in neoplastic meningitis.
    Pace A; Fabi A
    Crit Rev Oncol Hematol; 2006 Dec; 60(3):194-200. PubMed ID: 16949298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First human treatment of resistant neoplastic meningitis by intrathecal administration of MTX plus (125)IUdR.
    Rebischung C; Hoffmann D; Stefani L; Desruet MD; Wang K; Adelstein SJ; Artignan X; Vincent F; Gauchez AS; Zhang H; Fagret D; Vuillez J; Kassis AI; Balosso J
    Int J Radiat Biol; 2008 Dec; 84(12):1123-9. PubMed ID: 19061137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer].
    Hammerer V; Pauli G; Quoix E
    Bull Cancer; 2005 Nov; 92(11):989-94. PubMed ID: 16316833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
    Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
    Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplastic meningitis.
    Johns Hopkins Med J; 1982 Aug; 151(2):59-64. PubMed ID: 6896539
    [No Abstract]   [Full Text] [Related]  

  • 18. N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide.
    Moon KY; Kwon CH
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1673-8. PubMed ID: 9873412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Future prospects].
    Soffietti R
    Tumori; 2007; 93(3):suppl 14-5. PubMed ID: 17679483
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.
    Jaeckle KA
    Cancer Treat Res; 2005; 125():181-93. PubMed ID: 16211890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.